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Figure S1. Native polyacrylamide gel electrophoresis of mature fibrils showing no sign of smaller 
aggregates; Arrows indicate high molecular weight aggregates (top) and monomers (bottom), 
respectively. The abbreviation PF stand for protofibrils, M for monomers. The prepared amyloid 
fibrils are detectable in the gel pockets, while monomers or smaller protofibrillar Aβ(1-42) 
oligomers, which were used as controls, can enter the separating gel. This indicates that all three 
aggregate preparations contain large, relatively stable structures that cannot be dissociated with 
native polyacrylamide gels.
S3
Figure S2. Analysis of 1:1 Aβ(1-42):Aβ(1-40) mixed fibrils by AFM (A, B) and TEM (C, D). B) 
and D) show a detail from A and C in higher magnification (see frames). A) and B) color gradient: 
0-40 nm height. D) The line and the arrowheads illustrate how the length and breadth of fibrils were 
determined. Under the fibrillization conditions used in the present work the resulting fibrils appear 
short and highly associated in flat bundles, which do not disassemble to isolated fibrils upon 
sonication (data not shown). For length determination 592 fibrils have been measured which show 
an average length of 106.61 nm (SD = 54.75). For breadth determination 244 fibrils have been 
analyzed which show an average breadth of 3.25 nm (SD = 0.67).
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Figure S3. (A) Viability of primary hippocampal mouse neurons in a Cell-Titer blue assay after 72 
h treatment with 10 µM of pre-aggregated pure Aβ(1-40), pure Aβ(1-42), and mixture of Aβ(1-
42):Aβ(1-40) peptides in different ratios. In this assay only the 1:1 Aβ(1-42):Aβ(1-40) preparations 
induce a significant reduction of cell viability of about 30 % (Mean±St.Dev.,***p<0.001, 2-tailed 
unpaired t-test, comparison to untreated cells, n=3-4). All other preparations did not significantly 
reduce cell viability, indicating that they are less toxic than the 1:1 Aβ(1-42):Aβ(1-40) preparations. 
Note that non-aggregated and aggregated A preparations at a concentration below 10 M did not 
show any cytotoxicity under the same conditions. (B) Presence of fibrillar (Thioflavin-T reactive) 




Figure S4. A) 2D 15N-13C NCA spectra of the Aβ(1-42):Aβ(1-40) mixed fibrils in the 3:7 molar 
ratio (black) overlaid with the 2D 15N-13C NCA spectra of Aβ(1-42):Aβ(1-40) mixed fibrils in the 
1:1 molar ratio (red) and with fibrils of pure Aβ(1-40) (blue). Magnetic field: 700 MHz (16.4 T), 
dimension of rotor: 3.2 mm (~10-14 mg of fibrils), 14 kHz spinning, 100 kHz 1H decoupling. B) 2D 
13C-13C correlation spectra (in the region of the Cα of the isoleucine residues) of the Aβ(1-
42):Aβ(1-40) mixed fibrils in the 3:7 molar ratio (black) overlaid with the 2D 13C-13C correlation 
spectrum of Aβ(1-42):Aβ(1-40) mixed fibrils in the 1:1 molar ratio (red) and with 2D 13C-13C-
correlation spectrum of fibrils of pure Aβ(1-40) (blue). Magnetic field: 700 MHz (16.4 T), 










Figure S5. A) 2D 13C-13C correlation spectrum of the Aβ(1-42) aggregates. Magnetic field: 700 
MHz (16.4 T), dimension of rotor: 3.2 mm (~10-14 mg of aggregates), 12 kHz spinning, 100 kHz 
1H decoupling; B) 2D 15N-13C NCA spectrum of the Aβ(1-42). Magnetic field: 700 MHz (16.4 T), 
dimension of rotor: 3.2 mm (~10-14 mg of aggregates), 14 kHz spinning, 100 kHz 1H decoupling.
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Figure S6. (A) 2D 15N-13C NCA spectrum of the Aβ(1-42) component (black) overlaid with the 2D 
15N-13C NCA spectrum of the Aβ(1-40) component (red) in the 1:1 Aβ(1-42):Aβ(1-40) mixed 
fibrils; the full assignment of the spectrum is shown. (B) 2D 15N-13C NCA spectrum of the Aβ(1-
42) component (black), with the assignments of the S-shaped fibrils 1.
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Figure S7. Secondary structural analysis of Aβ(1-42):Aβ(1-40) mixed fibrils (1:1 ratio). Chemical 
shift differences with respect to the corresponding random coil values (panel A) and residue specific 
β-probabilities predicted by TALOS+ (panel B) are displayed. In panel A the red line indicates the 
cutoff of -1.4 ppm and the ∆δCα shifts for the glycines are displayed in light-grey.
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Table S1. Long-range intramolecular contacts between β1- and β2-strands observed and used for 
deriving the structural models of Aβ(1-42):Aβ(1-40) mixed fibrils in the present work.
Number Contacts Source spectra
1 H13 C1 - V40 C DARR (300 ms)
2 H13 C- V40 C2 DARR (300 ms)
3 H13 C- V40 C DARR (300 ms)
4 L17 C- L34 C2 DARR (100 ms)
5 L17 C- L34 C1 DARR (100 ms)
6 L17 C- L34 C DARR (100 ms)
7 L17 C1 - V36 C1 DARR (100 ms)
8 L17 N - L34 C2 PAIN(10ms)
9 L17 N - L34 C1 PAIN(10 ms)
10 F19 C1 - L34 C2 DARR (200 ms)
11 F19 C- G33 C DARR (100 ms)
12 A21 C- I32 C2 DARR (300 ms)
13 A21 C- I32 C1 DARR (100 ms)
14 A21 C- I32 C DARR (300 ms)
15 D23 C- A30 C DARR (100 ms)
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Figure S8. Folding of the monomeric Aβ(1-40) peptide in the model of 1:1 Aβ(1-42):Aβ(1-
40) mixed fibrils (A) and in the model obtained for the fibrils of pure Aβ(1-40) 2 (B).  It is clear 
that, in the current conformation of the β–arch, the contacts indicate a reciprocal packing of the two 
β-strands (β1 and β2) (A), which is different from that previously calculated for the fibrils of pure 
Aβ(1-40) 2 (B), but is consistent with the contacts observed in reference 10.
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Table S2. Long-range intermolecular contacts between two β2-strands observed and used for 
deriving the structural models of Aβ(1-42):Aβ(1-40) mixed fibrils in present work. The contacts of 
the side chains of Ile31 with Gly38/Val39/Val40, and of Met35 with Gly38/Val39, indicate the 
presence of a head-to-tail antiparallel association of two β2-strands of different monomers. These 
experimental restraints are in agreement with a two-fold rotational symmetry (also reported for the 
co-aligned homo-zipper model 3) and with the parallel registry of the protofilament.
Number Contacts Source spectra
1 M35 C- V39 C DARR (200 ms)
2 M35 C- G38 C PDSD (400 ms)
3 I31 C1 - G38 C PDSD (400 ms)
4 I31 C2 - G38 C PDSD (400 ms)
5 I31 C- V39 C1 DARR (200 ms)
6 I31 C1 - V39 C2 DARR (200 ms)
7 I31 C2 - V39 C DARR (100 ms)
8 I31 C2 - V39 C DARR (200 ms)
9 I31 C2 - V39 C2 DARR (100 ms)
10 I31 C2 - V40 C1 DARR (200 ms)
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Figure S9. Lateral packing of two different protofilaments in the model of 1:1 Aβ(1-
42):Aβ(1-40) mixed fibrils (A) and in the model of the fibrils of pure Aβ(1-40) 2 (B), calculated 
implementing long-range distance restraints in HADDOCK 4. The contacts and the generated model 
(A) are similar, but not identical, to those of the pure Aβ(1-40) (B) 2. In particular, the contacts 
Ile32-Val39, Gly33-Val39 and Met35-Gly37 are not observed in the mixed fibrils, while the 
additional contact between Ile31 and Val40 is observed because of the higher rigidity of Val40.
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Scheme S1. Different β-strand zippers in various SS-NMR-derived structural models of Aβ fibrils. 
The topologies of the β1-turn-β2 motif identified in the present work (A) and in other previously 
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studied Aβ(1-40) fibrils (B, D) 2,5–7 and Aβ(1-42) fibrils (C, E, F) 8–10 are shown in the left column. 
The dashed/dotted lines represent unambiguous experimental restraints used to derive the 
corresponding topology. In the schematic description of distinct structures of the U-shaped motif, 
the hydrophobic, acidic/basic, and other types of residues are shown in white, black, and gray, 
respectively. The topologies of the interprotofilament interface (β2-β2 zippers) in the fibrils 
determined in the present work (G) and proposed in previous studies (H, I, J, K) 2,5,6 are shown in 
the right column. The dashed lines represent unambiguous experimental restraints used to derive the 
corresponding topology. The filled black circles represent the Cε of the Met35 residue. Other 
residues included in SS-NMR-observed structural restraints for linking the two β2-strands are 
shown as hollow circles. Residues Ile41 and Ala42, in the present model of the mixed fibrils, are 
indicated with dashed circles to stress that both Aβ(1-40) and Aβ(1-42) share the same arrangement.
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Figure S10. Possible reciprocal packing modes of Aβ(1-40) and Aβ(1-42) peptides along 
the fibril axis generated and scored by HADDOCK 2.2 4: homogeneous protofilaments (all 
composed of either Aβ(1-40) or Aβ(1-42) peptides) that form a mixed cross-β structure (model A); 
interlaced protofilaments that form a paired (model B), or staggered (model C) cross-β structure. 
The Aβ(1-42) polypeptide is colored magenta and the Aβ(1-40) polypeptide in blue. The model of 
pure Aβ(1-40) fibrils is also displayed (panel D).2  Model A is excluded by the presence of cross-
peaks between the N-terminus and C-terminus of the β2 strand. Arrangements B and C are very 
similar and equally possible (see Table S3).
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Figure S11. 1D zTEDOR spectra of the Aβ(1-42):Aβ(1-40) mixed fibrils in the 1:1 molar 
ratio, where A) Aβ(1-42) is 15N-enriched and Aβ(1-40) is 13C-enriched and B) Aβ(1-42) is 15N-
enriched and Aβ(1-40) is in natural abundance, and C) Aβ(1-42) is in natural abundance and Aβ(1-
40) is 15N-13C-enriched. Magnetic field: 800 MHz (19 T, 201.2 MHz 13C Larmor frequency), 
dimension of rotor: 3.2 mm, 16 kHz spinning, 80 kHz 1H decoupling. The number of scans was 
tuned according to the sample amount (10240, for sample A and C, and 40960 for sample B). The 
signal of the backbone carbonyls appears only in (A), whereas it is absent in (B), confirming an 
interlaced arrangement. The spectrum (C) shows relatively lower intensity in the carbonyl region 
because the coupling across the hydrogen bond is masked by other intra-filament couplings. 
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Figure S12. Family of the best four structures corresponding to model B (left) and model C 
(right), obtained with an experimental restraint-driven calculation with HADDOCK 2.2. Two 
identical interlaced Aβ(1-40)/Aβ(1-42) protofilaments (left) and two different interlaced 
protofilaments, Aβ(1-40)/Aβ(1-42) and Aβ(1-42)/Aβ(1-40) (right) have been considered, 
respectively, in the calculations. The HADDOCK-scores for the models of the two families are not 
very different, although somewhat more favorable for the right-hand model (Table S3), so that firm 
conclusions for one or the other model cannot be drawn.
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Table S3. HADDOCK statistics evaluated on the 200 water refined models. The reported data are 
related to the best four structures of the clusters with the lowest HADDOCK-scores. The packing 
density and number of cavities have been evaluated using the Voronoia plugin in Pymol 11.
Model B Model C
HADDOCK-Score -353 ± 5 -267 ± 2
HADDOCK-Score 
(without EAIR) 
-394 ± 5 -299 ± 2
N° of structures of 
the cluster
199 200
RMSD 0.3 ± 0.2 0.3 ± 0.2
Desolvation Energy -185 ± 4 -150  ± 5
Buried surface area 
(BSA)




418 ± 23 321 ± 8
Average packing 
density 0.81 ± 0.01 0.82 ± 0.01
Number of cavities 22 ± 4 29 ± 5
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Table S4. HADDOCK statistics evaluated on the water refined models of model B, fibrils of pure 
Aβ(1-40) and fibrils of pure Aβ(1-42) in the S-shaped conformation after HADDOCK 
minimization. The reported data are related to the best four structures of the clusters with the lowest 
HADDOCK-scores. 




HADDOCK-Score -353 ± 5 -322 ± 3 -407 ± 0.4
HADDOCK-Score 
(without EAIR) 
-394 ± 5 -326 ± 3 -408 ± 0.4
RMSD 0.3 ± 0.2 0.2 ± 0.1 0.2 ± 0.1
Desolvation Energy -185 ± 4 -135 ± 4 -104 ± 5
Buried surface area 
(BSA)




418 ± 23 38 ± 4 15 ± 2
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Table S5. HADDOCK statistics evaluated on 20 water refined models. The reported data are 
related to the best four structures. The calculations were performed on the HADDOCK2.2 web-
server using the refinement interface. The models that were refined derived from calculations where 



































 20 20 20 20 20
RMSD 0.3 ± 0.2 0.3 ± 0.2 0.3 ± 0.2 0.3 ± 0.2 0.3 ± 0.2
Desolvation 
Energy









7 ± 2 19 ± 2 7 ± 2 18 ± 4 21 ± 1
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Methods
Expression, purification, and sample preparation of Aβ(1-42):Aβ(1-40) mixed fibrils
The cDNAs encoding the Aβ(1-40) and Aβ(1-42) polypeptides were cloned in the pET3a 
vector using the NdeI and BamHI restriction enzymes. The peptides were expressed in the BL21 
(DE3)pLys E. coli strain.
The peptides were purified as reported in the literature 2,13–16 with the modification of using a 
combination of anion-exchange and size exclusion chromatography. All the manipulations were 
performed at slightly alkaline pH in order to avoid the formation of structural contaminants 
produced by isoelectric precipitation. The inclusion bodies were first solubilized with 8 M urea and 
then purified by ion exchange chromatography performed in batch. All the obtained fractions of the 
diluted proteins were concentrated to a final volume using an Amicon device. The next step of 
purification was gel filtration, which was performed using the preparative column Sephadex 75 
HiLoad 26/60 with 50 mM (NH4)OAc pH 8.5 as a buffer. The obtained fractions were collected 
together and concentrated. During all the purification steps, the protein purity was analysed by 
SDS-PAGE, whereas the protein concentration was estimated spectrophotometrically.
Both Aβ(1-42) and Aβ(1-40) bear the exogenous N-terminal Met0 due to the introduction of 
a translation start codon that has been shown previously to not significantly influence aggregation 
or toxicity of Aβ aggregates 16,17. Both peptides were expressed using the Marley method 18, and 
purified as reported in literature 2,13–16 but using a combination of anion-exchange and size 
exclusion chromatography 2. These two-steps of purification allowed us to obtain highly pure 
products with the yield in the range of 10 mg for Aβ(1-40) and 5-10 mg for Aβ(1-42) per liter of 
culture 19–21.
The fibrils for SS-NMR studies were produced as described by Bertini et al. 2. Some 
samples were obtained by mixing 13C, 15N-uniformly enriched Aβ(1-40) polypeptide with Aβ(1-42) 
in natural isotopic abundance. Solutions containing Aβ(1-42) and Aβ(1-40) (total concentration of 
100 μM) in 50 mM ammonium acetate (pH 8.5) were incubated at 310 K under agitation (950 rpm) 
for 5 weeks. The 3:7 mixture sample was prepared using 30 μM and 70 μM of Aβ(1-42) and Aβ(1-
40) respectively, while the 1:1 sample was produced using the same concentration (50 μM) of both 
proteins. The 3:7 sample spontaneously resulted in two species (see main text), one of which 
corresponds to the previously characterized pure Aβ(1-40), and the other is a different species. 
Assuming that all the available Aβ(1-42) 30 μM formed fibrils with a stoichiometric amount of 
Aβ(1-40), 40 μM of Aβ(1-40) are free to form pure fibrils that, having a symmetric dimer as basic 
unit, contribute to 4/3 times the signal intensity of the other species, in line with the experimental 
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observation. Fibrils were collected by ultracentrifugation at 60,000 rpm and 277 K for 24 h. The 
pellet was washed with fresh and cold ultrapure water (Millipore) for three times (1 mL per time). 
About 14 mg of wet material were packed into a 3.2 mm ZrO2 magic angle spinning (MAS) rotor at 
277 K using an ultracentrifugal device (GiottoBiotech) 22,23. The fibril samples were kept fully 
hydrated during all steps. 
An equimolar mixture of 13C, 15N-uniformly enriched Aβ(1-42) polypeptide (50 μM) and 
Aβ(1:40) polypeptide (50 μM) in natural isotopic abundance was prepared using the same protocol. 
13C, 15N-uniformly enriched Aβ(1-42) fibrils were also grown, incubating the Aβ(1-42) 
polypeptide at the concentration of 20 μM to slow down the oligomerization process. 
Equimolar mixtures of Aβ(1-42) and Aβ(1-40) polypeptides with different labeling schemes 
[15N-uniformly enriched Aβ(1-42)/13C-uniformly enriched Aβ(1-40) and 15N-uniformly enriched 
Aβ(1-42)/natural isotopic abundance Aβ(1-40)] were also prepared following the same protocol. 
Preparation of A(1-42) monomer solutions and A(1-42) protofibrillar aggregates 
Synthetic A(1-42) peptide produced by Bachem (Bubendorf, Schwitzerland) was dissolved 
in 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) for three days, aliquoted and then lyophilized. 
Monomeric A(1-42) solutions were prepared by dissolving peptides in 10 mM NaOH, sonication 
for 5 min and dilution to the final concentration in low salt buffer (LSB, 1.9 mM KH2PO4, 8.1 mM 
K2HPO4, 10 mM NaCl, pH 7.4). Synthetic A(1-42) peptide produced by the laboratory of Dr. 
Volkmar-Engert (Institute for Medical Immunology, Charité, Berlin, Germany) was dissolved in 
HFIP overnight, sonicated for 30 min, aliquoted and then lyophilized. HFIP-treated peptide was 
dissolved in 100 mM NaOH, sonicated for 5 min and diluted in LSB to a final concentration of 200 
µM. The solution was incubated for 6 h in an Eppendorf Thermomixer (Wesseling-Berzdorf, 
Germany) at 310 K and 300 rpm. The protofibrillar aggregate species was aliquoted and stored at 
193 K.
Separation of A(1-42) aggregates by native gels. 
Aβ aggregates or monomers (4.5 µL, 10 µM) were diluted with NativePAGE 4x sample 
buffer (2.5 µL, Invitogen/Thermo Scientific, Dreieich, Germany) and LSB. Samples were loaded 
onto a Novex Bis-Tris 4-16% gel (Invitogen/Thermo Scientific, Dreieich, Germany) and separated. 
Aggregates were transferred to a nitrocellulose membrane (GE Healthcare, Freiburg, Germany) and 
visualized using the 6E10 antibody (BioLegend, San Diego, US) and a mouse anti-POD detection 
antibody (Sigma, Taufkirchen, Germany). Secondary antibody binding was detected by 
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chemiluminescence using ChemiGlow West Substrate (Alpha Innotech, Kasendorf, Germany); 
luminescence was measured using a FujiFilm LAS-3000 imager (Fuji, Kleve, Germany).
Microscopic characterization
For the AFM measurements of Aβ(1-42):Aβ(1-40) mixed fibrils, sheet mica (Glimmer V3; 
Plano, Wetzlar, Germany) was glued to a microscope slide and samples (20 μL) were adsorbed for 
10 min onto the freshly cleaved mica, washed with freshly filtered deionized water (4×30 μL) and 
dried overnight. Dry AFM images were recorded on a Nanowizard II/Zeiss Axiovert setup (JPK, 
Germany) using intermittent contact mode and PPP-NCHAuD probes (NANOSENSORS™, 
Neuchâtel, Switzerland). 
For the TEM measurement, samples of Aβ(1-42):Aβ(1-40) mixed fibrils were adsorbed onto 
formvar-carbon coated grids, stained with 5 % of uranyl acetate, and analyzed with a Morgagni 
electron microscope (Thermo Fisher), and a Morada camera. Pictures were taken and analyzed with 
the iTEM software (EMSIS GmbH, Münster, Germany).
Cell viability assay 
Primary hippocampal neurons were prepared from trypsinized brains of 17-days old 
C57/Bl6 mouse embryos, and plated out in minimal essential medium (Invitrogen, catalogue no. 
31095-029) supplemented with horse serum, penicillin, and streptomycin (PenStrep, Invitrogen, 
catalogue no. 15140-122). 4 h after plating, medium was replaced with Neurobasal medium (NB, 
Invitrogen, catalogue no. 21103-049) supplemented with B27 (Invitrogen, catalogue no. 17504-
044), and PenStrep. Neurons were grown in B27-supplemented Neurobasal medium for 10 days, 
and then were treated with 10 µM of pre-aggregated Aβ(1-40), Aβ(1-42) and a mixture thereof (Fig. 
S3 A). Pre-aggregation was obtained from recombinant monomers incubated at the concentration of 
100 M in Tris-EDTA buffer (50 mM Tris, 1 mM EDTA, pH 7.4) for 2 h at room temperature. At 
this stage, Aβ(1-42) and preparations Aβ(1-42):Aβ(1-40) 1:1 and 3:7 demonstrated a pronounced 
Thioflavin T (ThT) incorporation whilst Aβ(1-40) and Aβ(1-42):Aβ(1-40) 1:9 still had a very low 
content of aggregates (Figure S3 B). Aβ(1-40) aggregation was detectable at 10 h and 20 h of 
incubation, and aggregation of Aβ(1-42):Aβ(1-40) 1:9 increased at 20 h of incubation (Figure S3 
B). After 72 h treatment, 10 µL Cell-Titer-Blue dye (Promega) was added to 200 µL of the culture 
medium on the cells. After 3 h, the fluorescence intensity of the samples was measured at an 
excitation wavelength of 560 nm and an emission wavelength of 590 nm. Data was normalized to 
untreated cells (100%) and presented as MeanSt.Dev.; statistical significance is indicated by *** 
(Figure S3 A), p<0.001, 2-tailed unpaired t-test (comparison to untreated cells), n=3-4.
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NMR measurements
15N-13C NCA and NCO (2D), NCACX, NCOCX, NCACB, N(CO)CACB and CANCO (3D) 
experiments were performed either on a Bruker Avance III 850 MHz wide-bore spectrometer (20.0 
T, 213.7 MHz 13C Larmor frequency), or on a Bruker Avance II 700 MHz wide-bore spectrometer 
(16.4 T, 176.1 MHz 13C Larmor frequency) using 3.2 mm DVT MAS probeheads in triple-
resonance mode. MAS frequency (ωr/2π) was set to 17.0, 14.0 or 12.0 kHz (± 2 Hz) depending on 
the experiment. The NCA, NCO, NCACX, NCOCX, NCACB, N(CO)CACB and CANCO 
experiments were carried out using the pulse sequences reported in the literature 24,25. At 700 MHz 
NC transfers were achieved by optimal-control derived pulses 26. Backwards CN transfer was 
achieved with a time-reversal of the same optimal-control pulses. The amount of material used to 
fill the rotor was ~ 10-14 mg; NCA and NCO experiments were acquired using 256 and 128 scans, 
respectively, with an acquisition time on t1 dimension of 9 ms, and a recycle delay of 1.8 sec; 
NCACX and NCOCX experiments were acquired using 64 and 32 scans, respectively, with an 
acquisition time of 7 ms on t1 dimension and of 6 ms on t2 dimension, and a recycle delay of 1.9 
sec; NCACB and N(CO)CACB experiments were acquired using 64 and 144 scans, respectively, 
with an acquisition time of 5 ms on t1 dimension and of 4 ms on t2 dimension, and a recycle delay 
of 1.9 sec; CANCO experiment was acquired using 64 scans, with acquisition time of 5 ms on t1 
dimension and of 6 ms on t2 dimension, and recycle delay of 2 sec.
2D 13C-13C proton-driven spin diffusion (PDSD) 27, dipolar-assisted rotational resonance 
(DARR) 27,28 and Second-order Hamiltonian among Analogous Nuclei Generated by Hetero-nuclear 
Assistance Irradiation (SHANGHAI) 29 correlation spectra with different mixing times (15 to 800 
ms) were recorded on the 700 MHz instrument. For these experiments, the MAS frequency was 
stabilized at 12 kHz (± 2 Hz). SHANGHAI was included, with respect to the characterization 
reported in 2, because it warrants a more homogeneous transfer throughout signals at different 
frequencies at high field and moderate spinning rates. The 13C-13C correlation spectra were acquired 
using increasing number of scans with increasing mixing time (from 32 scans for shorter mixing 
times up to 96 scans for longer mixing times). For the sample of the 1:1 mixture of Aβ(1-42): Aβ(1-
40) were Aβ(1-42) is 13C-15N isotopically enriched higher number of scans were employed since the 
amount of material was smaller (~8-10 mg; number of scan from 128 to 256). The acquisition time 
on t1 dimension was 8 ms and the recycle delay 1.9 sec.
Bidimensional (2D 15N-13C hNhhC, 500 µs HH mixing time) and monodimensional 
(zTEDOR, 10 ms mixing time) nitrogen and carbon correlation spectra were recorded on a Bruker 
AvanceIII spectrometer operating at 800 MHz (19 T, 201.2 MHz 13C Larmor frequency) equipped 
with Bruker 3.2 mm Efree NCH probe-head. The spectra were recorded at 16 kHz (± 2 Hz) MAS 
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frequency; the number of scans was 2048 for the bidimensional (10 ms of acquisition time on t1 
dimension) and 10240 or 40960 (according to the fibril amount) for the monodimensional 
experiments, respectively; the recycle delay was 3 sec. 
In all cases, 1H decoupling was applied at 80-100 kHz (optimized on the basis of the 13C' 
echo lifetime 30) using swfTPPM 31–33. During the experiments, the sample was cooled by a dry, 
cold air flow (> 935 L/h), and the effective sample temperature was estimated to be ∼283 K 23. 
Spectra were analyzed by the program CARA (Computer Aided Resonance Assignment, 
ETH Zurich) 34. 
SS-NMR data analysis and structural modeling.
Sequential assignment of the new species present in the Aβ(1-42):Aβ(1-40) mixed fibrils, 
where either Aβ(1-40) or Aβ(1-42) was 13C, 15N-uniformly enriched, was performed using the same 
procedure for both samples, starting from the identification of the residues 31Ile-32Ile. These two 
consecutive residues can be identified following the signals of the two sidechains, which can be 
easily distinguished in the 2D 13C-13C correlation spectra. Starting from these residues, the 
sequential assignment was obtained by analyzing the 3D 15N-13C spectra according to the procedure 
reported by Bertini et al. 2. The assignment is deposited in the BMRB with ID 34455). The 
secondary structure was predicted by TALOS+ 35 using the chemical shifts of the N, C, Cα and Cβ. 
For model building, the length of the β1 and β2 strands was based on the secondary structure 
predicted by TALOS+. The β1- and β2-strands were then docked to one another by HADDOCK 4 
using all the experimental long-range β1-β2 restraints. HADDOCK calculations were performed on 
the WeNMR GRID (http://www.wenmr.eu/, Guru interface, see supporting information for details). 
The β-sheets were then generated by duplicating the β1 and β2 strands along the direction of 
the backbone N-H and C=O bonds with PYMOL, using the inter-strand distance of 4.8 Å 36, typical 
of the parallel register. Eight β-strands for each β1 and β2 sheets were generated, considering for the 
β2-sheet an interlaced arrangement of the Aβ(1-40) and Aβ(1-42) monomers.
The turn regions were randomly generated using MODELLER 37 and the final one was 
selected from the resulting pool of 50 structures. 
The inter-protofilament structural models were generated by docking calculations starting 
from two β2-sheets belonging to two different protofilaments and imposing non-crystallographic 
symmetry restraints between the two β2-sheets.
During HADDOCK calculations, first the β1- and β2-strands were docked to one another, 
using all the experimental long-range β1-β2 restraints of β1- and β2-strands. The lower distance 
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cutoff was set to 3.0 Å, and the upper to 6.0 Å for the shorter mixing times (100 and 200 ms) and to 
7.5-8.0 Å for longer mixing (300 and 400 ms). The charges on the N- and C-termini of the β1-
strands and on the N-termini of the β2-strands were not included in the calculations in order to 
prevent electrostatic interactions, which do not exist when the two β-strands are linked by a turn 
region. The histidine protonation states were automatically determined by the Molprobity module 
embedded in the HADDOCK server. During the rigid docking calculations, 1000 structures were 
generated, then the best 200 structures were selected for the semi-rigid simulated annealing in 
torsion angle space, and finally refined in Cartesian space with explicit solvent.
The structural models were then generated by implementing in the calculations all the 
observed intermolecular β2-β2 long-range contacts and inter-strand distance restraints. All the 
restraints were duplicated symmetrically between the two β2-sheets using the same protocol used 
for structural calculations of symmetric protein dimers. Since these long-range distance restraints 
could be identified only using long mixing times, the upper distance cutoffs in the HADDOCK 
calculation was set to 8.0 Å. Semi-flexible refinement was enabled on both β2-sheets. 
The family of structures obtained for the mixed Aβ(1-42) and Aβ(1-40) fibrils have been 
deposited in the protein data bank (model B, PDB ID: 6TI6 and model C, PDB ID:6TI7), together 
with the structure of the pure Aβ(1-40) fibrils previously reported by Bertini and co-workers (model 
D, PDB ID: 6TI5, BMRB ID: 34454) 2.
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